Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study

BMC Musculoskeletal Disorders

Volumn 8, Issue , 2007, Pages

  Cuatrecasas, Guillem ^a   Riudavets, Cristina ^a   Güell, Maria Antònia ^a   Nadal, Albert ^a  

^a CENTRO MÉDICO TEKNON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBROMYALGIA; HUMAN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; BLOOD; FOLLOW UP; HOSPITALIZATION; KINESIOTHERAPY; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PILOT STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; FIBROMYALGIA; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 38649128133     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-8-119     Document Type: Article

References (18)

1. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. F Wolfe HA Smythe MB Yunus RM Bennett C Bombardier DL Goldenberg P Tugwell SM Campbell M Abeles P Clark, Arthritis Rheum 1990 33 160 72 10.1002/art.1780330203 2306288
2. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. L Carmona J Ballina R Gabriel A Laffon on behalf of the EPISER Study Group, Ann Rheum Dis 2001 60 1040 5 11602475 10.1136/ard.60.11.1040
3. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. P Mease, J Rheumatol Suppl 2005 75 6 21 16078356
4. Psychological evaluation of patients diagnosed with fibromyalgia syndrome: a comprehensive approach. DC Turk ES Monarch AD Williams, Rheum Dis Clin North Am 2002 28 219 33 10.1016/S0889-857X(01)00003-5 12122915
5. The neuropharmacology of centrally-acting analgesic medications in fibromyalgia. SG Rao, Rheum Dis Clin North Am 2002 28 235 59 10.1016/S0889-857X(01)00004-7 12122916
6. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. F Tanriverdi Z Karaca K Unluhizarci F Kelestimur, Stress 2007 10 13 25 10.1080/10253890601130823 17454963
7. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. RM Bennett DM Cook SR Clark CS Burckhardt SM Campbell, J Rheumatol 1997 24 1384 9 9228141
8. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. A Leal-Cerro J Povedano R Astorga M Gonzalez H Silva F Garcia-Pesquera FF Casanueva C Dieguez, J Clin Endocrinol Metab 1999 84 3378 81 10.1210/jc.84.9.3378 10487713
9. Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. ES Paiva A Deodhar KD Jones R Bennett, Arthritis Rheum 2002 46/5 1344 50 10.1002/art.10209
10. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. CJ Malemud, Clin Chim Acta 2007 375 10 9 10.1016/j.cca.2006.06.033 16893535
11. Rational management of fibromyalgia. RM Bennett, Rheum Dis Clin North Am 2002 28 xiii xv 10.1016/S0889-857X(02)00006-6 12122930
12. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. RM Bennett SC Clark J Walczyk, Am J Med 1998 104 227 31 10.1016/S0002-9343(97)00351-3 9552084
13. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. J Rivera T Gonzalez, Clin Exp Rheumatol 2004 22 554 60 15485007
14. [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. X Badia M Roset S Montserrat M Herdman A Segura, Med Clin (Barc) 1999 112 Suppl 1 79 85 [Article in Spanish] 10618804
15. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. R Bennett, Clin Exp Rheumatol 2005 23 5 Suppl 39 S154 S162 16273800
16. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. HS Picavet N Hoeymans, Ann Rheum Dis 2004 63 723 9 15140781 10.1136/ard.2003.010769
17. Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. JS McCall-Hosenfeld DL Goldenberg S Hurwitz GK Adler, J Rheumatol 2003 30 809 14 12672204
18. Usefulness of different biochemical markers of the insulin-like growth factor (igf) family in diagnosing growth hormone excess and deficiency in adults. P Marzullo C di Somma KL Pratt J Khosravi A Diamandis G Lombardi A Colao RG Rosenfeld, J Clin Endocrinol Metab 2001 86 3001 8 10.1210/jc.86.7.3001 11443159